FDA Approves Eli Lilly's GLP-1 Pill
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.
schedule
18:56
visibility
42 просмотров
Источник: Wired
Читать оригинал →
auto_awesome Эта статья переведена автоматически и может содержать неточности.
Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill version of Wegovy.